Stay updated on Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page history revision label advanced from v3.6.2 to v3.6.3, indicating a new version of the page has been released.SummaryDifference0.0%

- Check23 days agoChange DetectedA new revision entry, Revision: v3.6.2, has been added to the Study Record History, replacing Revision: v3.6.0. This indicates a minor platform update to the history view.SummaryDifference0.0%

- Check37 days agoChange DetectedThe study page now shows that recruitment has ceased. The page revision is updated to v3.6.0, replacing the previous version.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry v3.5.5 was added to the record history, and the previous v3.5.4 entry was removed. This update represents an administrative adjustment to the study's revision history.SummaryDifference0.0%

- Check66 days agoChange DetectedA new site revision entry, Revision: v3.5.4, was added to the history, superseding the previous Revision: v3.5.3.SummaryDifference0.0%

- Check87 days agoChange DetectedThe page’s displayed ClinicalTrials.gov revision/version number has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.